Vardenafil More Effective When Used On-Demand for Erectile Dysfunction
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Vardenafil More Effective When Used On-Demand for Erectile Dysfunction

AMSTERDAM, Netherlands -- August 26, 2008 -- Vardenafil is more efficacious when used on-demand versus nightly in men with erectile dysfunction following bilateral nerve-sparing radical prostatectomy (NSRP), according to a study published in the October issue of European Urology.

The multicentre study recruited patients 1 month before they were scheduled to undergo NSRP, between December 2004 and September 2007. A total of 423 patients completed the study.

The inclusion of the on-demand dosing regimen enabled comparison of the currently recommended guidelines for the use of phosphodiesterase type 5 (PDE5) inhibitors with a proposed nightly dosing regimen, which was suggested to have potential positive effects on erectile function.

The results of the study showed that on-demand use of vardenafil during the treatment period was associated with significantly greater erectile function and sexual intercourse completion rates compared with placebo.

The success rates for the vardenafil on-demand group were also higher than for the nightly group. These data indicate that the use of on-demand vardenafil is of greater benefit than nightly treatment in patients following NSRP surgery and, in general, support the on-demand use of PDE5 inhibitors following NSRP surgery over a daily dosing regimen.

According to the authors, this prompts reconsideration of the current practice of prescribing nightly PDE5-inhibitor therapy, as on-demand use of vardenafil is equally effective in men with ED following NSRP, a notoriously difficult-to-treat patient population.

SOURCE: Elsevier

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities